You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mesothelin expression

Showing 1 - 25 of 5,172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Philadelphia (huCART-meso cells, Mesothelin Expression Testing)

Not yet recruiting
  • Breast Cancer
  • huCART-meso cells
  • Mesothelin Expression Testing
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 5, 2023

Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,

Active, not recruiting
Has Results
  • Neoplasms With Mesothelin Expression
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2022

Advanced Cancers Associated With Mesothelin Expression Trial in United States (HPN536)

Active, not recruiting
  • Advanced Cancers Associated With Mesothelin Expression
  • HPN536
  • Phoenix, Arizona
  • +15 more
Sep 9, 2022

Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,

Active, not recruiting
  • Lung Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 4, 2022

Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)

Completed
Has Results
  • Neoplasms
  • Pancreatic Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 16, 2022

Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

Not yet recruiting
  • Malignant Pleural Mesotheliomas (Mpm)
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

Not yet recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • Anti-mesothelin CAR-T cells
  • (no location specified)
Mar 13, 2023

Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

Recruiting
  • Pancreas Cancer
  • +3 more
  • CAR-T cells
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Mar 10, 2023

Refractory Malignant Solid Tumor Trial in Shanghai (anti-MESO CAR T cells)

Recruiting
  • Refractory Malignant Solid Neoplasm
  • anti-MESO CAR T cells
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Sep 16, 2021

Pancreatic Cancer Trial in Shatin (MSLN CART)

Not yet recruiting
  • Pancreatic Cancer
  • MSLN CART
  • Shatin, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Sep 19, 2023

Clinical Management of Esophageal Adenocarcinoma (EAC)

Active, not recruiting
  • Esophageal Cancer
  • Adenocarcinoma
  • serum and tissue mesothelin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 1, 2021

Pleural Malignant Mesothelioma Trial in Canada, United States (Anetumab Ravtansine, Laboratory Biomarker Analysis,

Active, not recruiting
  • Pleural Malignant Mesothelioma
  • Anetumab Ravtansine
  • +3 more
  • Birmingham, Alabama
  • +32 more
Dec 24, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Lung Cancer, Cancer, Immunotherapy Trial in Guangzhou (CAR-T cells targeting PSCA, MUC1, TGFß, HER2, Mesothelin, Lewis-Y, GPC3,

Recruiting
  • Lung Cancer
  • +3 more
  • CAR-T cells targeting PSCA, MUC1, TGFβ, HER2, Mesothelin, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2, or B7-H3
  • Guangzhou, Guangdong, China
  • +1 more
Nov 26, 2021

Oncology Trial in United States (BAY94-9343, BAY94-9343 (Expansion), BAY94-9343 (1.8 mg/kg))

Completed
  • Oncology
  • New Haven, Connecticut
  • +7 more
Jul 6, 2021

Study of Patients With Malignant Mesothelioma

Recruiting
  • Mesothelioma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

    Completed
    Has Results
    • Mesothelioma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 28, 2022

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    Spread of Colorectal Carcinomatosis

    Completed
    • Peritoneal Carcinomatosis
    • Sampling peritoneal tissue
    • Ghent, Belgium
      Ghent University Hospital
    Dec 9, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)

    Active, not recruiting
    • Advanced Solid Tumors
    • AMG 994
    • AMG 404
    • Duarte, California
    • +16 more
    Nov 16, 2022

    Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

    Recruiting
    • Mesothelin-positive Advanced Malignant Solid Tumors
    • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital Zhejiang University School of Medi
    May 11, 2023

    Solid Tumor Trial (UCLM802 Cell Injection)

    Not yet recruiting
    • Solid Tumor
    • UCLM802 Cell Injection
    • (no location specified)
    Mar 7, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Autologous Mesothelin-specific TCR-T Cells
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 31, 2023

    Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • +8 more
    • AB-1015
    • Iowa City, Iowa
      U. of Iowa Health Care
    Jan 30, 2023